InvestorsHub Logo
Followers 0
Posts 213
Boards Moderated 0
Alias Born 07/31/2017

Re: goforthebet post# 6552

Thursday, 07/19/2018 9:36:04 AM

Thursday, July 19, 2018 9:36:04 AM

Post# of 18220
Interesting information, BUT the most obvious aspect is how does this benefit IMUN. You and all other stockholders must know that in order to benefit from use of LDN as a therapy, IMUN, like all other Biotech/Biopharma companies MUST receive FDA New Drug Application (NDA) approval to market the drug. NO IF, ANDS OR BUTS about it. And to do that clinical trials approved and monitored by the FDA need to be done!